The efficacy and safety of bupropion sustained-release formulation for the treatment of major depressive disorder: a multi-center, randomized, double-blind, placebo-controlled study in Asian patients

This study was conducted to compare the efficacy and safety of bupropion sustained-release (SR) formulation orally administered at daily doses of 150 mg/day (once daily) and 300 mg/day (150 mg twice daily) for 8 weeks versus placebo in Asian patients with major depressive disorder. The mean change f...

Descripción completa

Detalles Bibliográficos
Autores principales: Koshino, Yoshifumi, Bahk, Won-Myong, Sakai, Hideaki, Kobayashi, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3770623/
https://www.ncbi.nlm.nih.gov/pubmed/24039429
http://dx.doi.org/10.2147/NDT.S48158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3770623/
https://www.ncbi.nlm.nih.gov/pubmed/24039429
http://dx.doi.org/10.2147/NDT.S48158

Ejemplares similares